Evidence map›Paper›PMID 36644526›Full record

ArticleInorganic chemistry communications2023

Fabrication of Fe(III)-doped mesoporous silica nanoparticles as biocompatible and biodegradable theranostic system for Remdesivir delivery and MRI contrast agent.

Hasan Arkaban, Javad Jaberi, Ali Bahramifar, Reza Zolfaghari Emameh, Gholamreza Farnoosh, Mehdi Arkaban, Ramezan Ali Taheri

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Inorganic chemistry communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Hasan ArkabanNanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Javad JaberiDepartment of Chemistry, University of Isfahan, Isfahan 81746-73441, Iran.
Ali BahramifarTrauma Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Reza Zolfaghari EmamehDepartment of Energy and Environmental Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
Gholamreza FarnooshApplied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Mehdi ArkabanDepartment of Chemistry, Islamic Azad University of Dorud, Iran.
Ramezan Ali TaheriNanobiotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Baqiyatallah University of Medical Sciences · IRBiotechnology Research Center · IRIslamic Azad University, Tehran · IRNational Institute of Genetic Engineering and Biotechnology · IRUniversity of Isfahan · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus causes the majority of common colds and is spread in the same way that all viruses attack the respiratory system. Despite the trials and efforts to produce a suitable vaccine, there are solutions for the quick, effective and efficient use of existing drugs to prevent infections and improve the condition of patients. In this study, we synthesized mSiO

Indexed as

Biodegradable SiO2 nanoparticleCoronavirusDrug deliveryPolydopamineRemdesivir

Identifiers

PMID36644526
PMCPMC9827735
OpenAlexW4313837469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.